# SHL Pharma LLC – FDA 483, Jul 11, 2019

Source: https://www.keypedia.com/records/483/shl-pharma-llc/a6b548f8-59f8-44de-8c9c-c5575ec5300e

> FDA 483 for SHL Pharma LLC on July 11, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: SHL Pharma LLC
- Inspection Date: 2019-07-11
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: An FDA inspection of GTT Pharma, LLC in Deerfield Beach, FL, revealed significant deficiencies in their quality system, specifically regarding the investigation of out-of-specification (OOS) results. The firm failed to adequately document conclusions and implement corrective and preventative actions for multiple OOS investigations related to drug product stability testing, leading to continued failures. This indicates a breakdown in their quality control processes for handling product deviations.

## Related Documents

- [EIR - 2019-01-29](https://www.keypedia.com/records/eir/shl-pharma-llc/db56a567-e4c5-486f-b926-48bea9f687ea) — date: January 29, 2019

## Related Officers

- [Jason D Abel](https://www.keypedia.com/people/jason-d-abel/42c4bafe-17bb-4a43-80cd-83dd77b3426d)
- [Jennifer L. Huntington](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)

Company: https://www.keypedia.com/companies/shl-pharma-llc/bf3ea56c-78f5-4e22-9b0f-ffe5ee693aa3

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6
